Objective-Angiogenesis, the process of building complex vascular structures, begins with sprout formation on preexisting blood vessels, followed by extension of the vessels through proliferation and migration of endothelial cells. Based on the potential therapeutic benefits of preventing angiogenesis in pathological conditions, many studies have focused on the mechanisms of its initiation as well as control. However, how the extension of vessels is terminated remains obscure. Thus, we investigated the negative regulation mechanism. Approach and Results-We report that increased intracellular calcium can induce dephosphorylation of the endothelial receptor tyrosine kinase Tie2. The calcium-mediated dephosphorylation was found to be dependent on Tie2-calmodulin interaction. The Tyr1113 residue in the C-terminal end loop of the Tie2 kinase domain was mapped and found to be required for this interaction. Moreover, mutation of this residue into Phe impaired both the Tie2-calmodulin interaction and calcium-mediated Tie2 dephosphorylation. Furthermore, expressing a mutant Tie2 incapable of binding to calmodulin or inhibiting calmodulin function in vivo causes unchecked growth of the vasculature in Xenopus. Specifically, knockdown of Tie2 in Xenopus embryo retarded the sprouting and extension of intersomitic veins. Although human Tie2 expression in the Tie2-deficient animals almost completely rescued the retardation, the Tie2(Y1113F) mutant caused overgrowth of intersomitic veins with strikingly complex and excessive branching patterns. Conclusions-We propose that the calcium/calmodulin-dependent negative regulation of Tie2 can be used as an inhibitory signal for vessel growth and branching to build proper vessel architecture during embryonic development.
D uring embryogenesis, vascular network formation depends on 2 distinct and sequential processes. The first is vasculogenesis, wherein endothelial progenitor cells differentiate, migrate, and coalesce to form the primordial vessels and heart. 1 This is followed by angiogenesis, in which endothelial cells in the primordial vessels sprout and branch, forming the complex vascular system. 1 A key regulator of these events is the receptor tyrosine kinase Tie2, which is expressed exclusively in endothelial cells. 2, 3 Genetically inhibiting Tie2 in mice impairs vasculogenesis by decreasing proliferation and survival of the endothelial cells. 4 In addition, Tie2 knockout mice exhibit significant defects in angiogenesis, such as reduced capillary sprouting in the head region and indistinct large and smaller blood vessels. 5 In contrast, increasing the Tie2 activity by overexpressing its agonistic ligand, angiopoietin-1 (Ang1), 6 in the skin increases the number, size, and branching of blood vessels in mice. 7 Meanwhile, overexpressing the antagonistic ligand, Ang2, phenocopies the loss of Tie2 function. 8 Therefore, Ang/Tie2 signaling plays a pivotal role in formation of the vascular network during development.
In adult vasculature, modulation of Tie2 signaling is essential for vessel remodeling, especially in pathological conditions. 2, 9 Notably, rapidly growing tumors release angiogenic factors and promote vessel growth toward themselves to maintain a constant supply of oxygen and nutrients. Improper blood vessel remodeling is also key to eye diseases, such as age-related macular degeneration and diabetic retinopathy. 10 In addition, during sepsis, impaired vessel integrity increases the permeability of immune cells, leading to systematic inflammation. [11] [12] [13] Because enhancing the vessel-stabilizing effect of Tie2 signaling might be beneficial to the treatment of these diseases, many research laboratories and pharmaceutical companies are working toward developing drugs, which can modulate Tie2 activity. [14] [15] [16] [17] Despite the importance of Tie2 regulation in both embryonic vascular development and pathological angiogenesis, negative regulatory mechanisms of the receptor have not yet been elucidated. Dephosphorylation of Tie2 by tyrosine phosphatases, such as Src homology region 2-containing protein tyrosine phosphatase-2 (SH-PTP2) and vascular endothelial protein tyrosine phosphatase (VE-PTP), has been suggested previously. 18, 19 However, what controls such dephosphorylation remains largely unknown. Here, we show that increased intracellular calcium in endothelial cells induces dephosphorylation of Tie2. We also demonstrate that the calcium-mediated Tie2 dephosphorylation depends on Tie2-calmodulin interaction. Disrupting this interaction during embryogenesis leads to uncontrolled vessel growth and branching. Thus, we propose that the calcium/calmodulin-dependent negative regulation of Tie2 acts as a developmental brake for vessel outgrowth to build a proper vascular network.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Increased Concentrations of Intracellular Calcium Decrease Tie2 Phosphorylation
To investigate a possible connection between calcium and Tie2 signaling, we treated human umbilical vein endothelial cells (HUVECs) with Ang1 (an agonistic ligand of Tie2) and a calcium ionophore. We then visualized Tie2 phosphorylation using an antibody that specifically detects the phosphorylated form of Tie2. Compared with untreated controls, Ang1-treated cells were clearly stained for phosphorylated Tie2, particularly at the cellcell contact regions ( Figure 1A ). This observation agrees with previous reports that Ang1 and Tie2 form complexes at cell-cell contacts. 20, 21 Treatment with calcium ionophore caused retraction of the cells, leading to loss of cell-cell contacts (Figures IA and IB in the online-only Data Supplement). Ang1-dependent Tie2 phosphorylation observed in cell-cell contacts was markedly reduced by cotreatment of calcium ionophore ( Figure 1A ), whereas the loss of cell-cell contacts by calcium ionophore was partially rescued on cotreatment with Ang1 ( Figure 1A ; Figures IA and IB in the online-only Data Supplement). This pattern of responses was more evident when Tie2 expression was increased in HUVECs by infecting them with lentivirus encoding Tie2 fused with green fluorescent protein (Tie2-GFP) ( Figure IC in the online-only Data Supplement). This result indicates that intracellular calcium and Ang1 can antagonistically regulate Tie2 phosphorylation. Subsequent biochemical analysis also showed that calcium ionophore reduces Ang1dependent Tie2 phosphorylation ( Figure 1B, lanes 2 and 4) . Therefore, we concluded that increased intracellular calcium levels negatively regulate Tie2 phosphorylation.
Next, to investigate the molecular mechanism underlying the calcium-induced Tie2 dephosphorylation, we used a constitutively active form of Tie2, Tie2ΔECD, 22 expressed in human embryonic kidney 293T cells (HEK293T). The Tie2 mutant lacking the extracellular domain (ECD) was properly targeted to the cell surface ( Figure IIA in the online-only Data Supplement) and exhibited a high level of ligand-independent phosphorylation ( Figure 1C , lane 2) as previously reported. 22 This might be attributed to its propensity to dimerize, even in the absence of a ligand, through its coiled-coil domain in the membrane proximal region of the Tie2 cytoplasmic tail. 22 Unlike the endogenous Tie2 protein expressed in HUVECs, however, calcium ionophore treatment did not reduce the phosphorylation of Tie2ΔECD, ectopically expressed in HEK293T cells ( Figure 1C , lane 3). We reasoned that this might result from the amount of ectopically expressed Tie2 molecules, which exceeds the relatively lower amount of, if any, an endogenously expressed calcium effector molecule. In agreement with this idea, when expression of the Tie2ΔECD was reduced, phosphotyrosine level was indeed decreased by calcium ionophore in HEK293T cells ( Figure IIB in the online-only Data Supplement). In addition, coexpression of a calcium effector protein, calmodulin, with Tie2ΔECD in HEK293T cells fully restored calcium-mediated reduction of tyrosine phosphorylation ( Figure 1C , lane 5), indicating that calmodulin may work as a calcium effector mediating the calcium-induced Tie2 dephosphorylation. The reduction of Tie2 phosphorylation by calcium ionophore is calcium-specific because it did not occur when extracellular calcium ion was replaced with magnesium or manganese ion ( Figure 1D ). We also found that W-7, a calmodulin antagonist that inhibits calcium-dependent interaction between calmodulin and its target, 23 inhibits the ionophoreinduced Tie2 dephosphorylation ( Figure 1E ), indicating that calmodulin mediates calcium-induced Tie2 dephosphorylation.
Calmodulin Binds to C-Terminal Region of theTie2 Cytoplasmic Tail
Calmodulins relay calcium signaling by binding to and regulating the activity of their partners in a calcium-dependent manner. 24 Having established that calcium-dependent dephosphorylation of Tie2 requires calmodulin ( Figure 1C ), we asked whether calmodulin binds to Tie2. We found that Tie2 expressed in HEK293T cells binds to calmodulin-conjugated (but not control) beads (Figure 2A ), indicating that Tie2 and calmodulin may form a complex. Proximity ligation assay performed in HUVECs using antibodies against calmodulin and Tie2 also suggested that Tie2 and calmodulin form complexes in physiological conditions ( Figure III in the online-only Data Supplement). Next, we observed interaction between Figure 2B , lane 1). These data demonstrate that calmodulin specifically binds to the cytoplasmic domain of Tie2. To pinpoint the calmodulin-binding site in Tie2, we first prepared a series of deletion mutants: Tac-Tie2Δ909, in which the C-terminal lobe of the kinase domain was deleted; Tac-Tie2Δ879, containing a part of the N-terminal lobe only; and Tac-Tie2Δ840, with the entire kinase domain deleted, leaving only the membrane proximal region ( Figure 2C ). All these mutants failed to bind to calmodulin ( Figure 2B Figure 1 . Calcium-and calmodulin-dependent dephosphorylation of Tie2. A, Human umbilical vein endothelial cells (HUVECs) grown on cover slips were starved for serum, treated with 0.5 μg/mL angiopoietin-1 (Ang1) and 10 μmol/L calcium ionophore for 15 minutes as indicated, and subsequently stained with a phospho-specific Tie2-pY992 antibody (red) and an anti-Tie2 extracellular domain (anti-Tie2 ECD) antibody (green). Phosphotyrosine staining pattern in cell-cell contact regions is evident in Ang1-treated cells (arrows), but cotreatment with ionophore reduced the staining in the region. Scale bar, 10 μm. B, Subconfluent HUVECs were starved for serum and stimulated with Ang1 and calcium ionophore as indicated. The degree of Tie2 phosphorylation in these cells was analyzed by immunoprecipitation using anti-Tie2 ECD antibody and Western blot using the phospho-specific Tie2-pY992 antibody (top). Equal amounts of precipitated Tie2 in each condition were also analyzed using anti-Tie2 intracellular domain (ICD) antibody (bottom). C, FLAG-tagged Tie2ΔECD (extracellular domain-deleted Tie2 construct, FLAG-Tie2ΔECD) was transfected into human embryonic kidney 293T (HEK293T) cells with or without HA-tagged calmodulin (HA-CaM). Cells were treated with calcium ionophore, FLAG-Tie2ΔECD was immunoprecipitated (IP) by anti-FLAG antibody, and the phosphotyrosine level was measured by Western blotting (WB) using anti-phosphotyrosine antibody (anti-pY, upper panel). The membrane was reprobed with horseradish peroxidase (HRP)-conjugated anti-Tie2 antibody to examine the degree of Tie2 precipitation in each condition (middle). Calmodulin expression in whole cell lysates was monitored by Western blotting using anticalmodulin antibody (lower). Both endogenous (lower) and overexpressed HA-tagged (upper) calmodulin are visible. D, HEK293T cells transfected with FLAG-Tie2ΔECD and HA-CaM were starved for serum and incubated in the presence of divalent cations as described in Materials and Methods. The degree of phosphorylation of FLAG-Tie2ΔECD was analyzed as in C. E, HEK293T cells transfected with FLAG-Tie2ΔECD and HA-CaM were treated with ionophore alone or together with a calmodulin antagonist, W-7. Arrowheads in C, D, and E indicate immunoglobulin heavy chain.
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indicating that calmodulin binding requires the C-terminal lobe of the Tie2 kinase domain. A deletion in the lobe after the Y1102 residue also completely abolished calmodulin binding ( Figure 2D , Tie2Δ1102 in lane 7). The deleted region forms a loop (shown in red in Figure 2C ) and is known to bind to downstream signaling molecules in a phosphorylation-dependent manner. 25, 26 Thus, we hypothesized that tyrosine residues in the C-terminal loop are involved in calmodulin binding. To test this, we mutated 3 tyrosine residues, Y992, Y1108, and Y1113, in the C-terminal loop ( Figure 2D ) into phenylalanine (F) and measured the calmodulin binding. Y1113F dramatically reduced the binding, showing that this residue is critical for the Tie2-calmodulin interaction. Introduction of the negatively charged glutamic acid (E) at the Tyr1113 site also reduced its binding to calmodulin ( Figure 2E ), suggesting that any modification of the Tyr1113 residue inhibits calmodulin binding. A close examination of the crystal structure of the Tie2 kinase domain revealed that the hydroxyl group in the side chain of the Tyr1113 residue forms a hydrogen bond with the backbone amino group of Leu920 ( Figure 2F ). This places the phenyl ring of Tyr1113 in the hydrophobic pockets formed by neighboring amino acids. 27 This interaction positions the C-terminal loop region near the C-terminal lobe of the kinase domain. The possibility that Tyr1113 is the direct binding interface between Tie2 and calmodulin cannot be ruled out. However, the position of the hydroxyl group of the Tyr residue inside the hydrophobic pocket, in all crystal structures published to date, suggests that the conformation of the C-terminal loop itself is more likely to be responsible for calmodulin interaction. Therefore, either absence of the hydroxyl group on the aromatic ring (in case of Y1113F) or presence of the bulky and negatively charged residue (in case of Y1113E) might displace the C-terminal loop region away from the C-terminal lobe of the kinase domain, as suggested previously. 27, 28 We reason that this structural change might prevent calmodulin binding in Y1113F mutant.
Tie2-Calmodulin Interaction Is Required for Calcium-Mediated Tie2 Inactivation
Having identified the mutation that disrupts the Tie2-calmodulin interaction, we used a calmodulin binding-defective Tie2 mutant to test the importance of this interaction in calcium-mediated Tie2 inactivation. To this end, we transfected HEK293T cells with the constitutively active Tie2ΔECD construct, containing either the wild-type sequence or Y1113F mutation, treated them with calcium ionophore, and measured the phosphotyrosine levels in the immunoprecipitated Tie2 proteins. In contrast to wild-type Tie2, whose phosphorylation was significantly decreased by calcium ionophore ( Figure 3A and 3B), the calmodulin binding-defective Y1113F mutant was resistant to calcium ionophore-induced dephosphorylation ( Figure 3A and 3B). These results indicate that together with the requirement for calmodulin expression in calcium-dependent inactivation of Tie2 ( Figure 1C ), binding of calmodulin to the Tie2 C-terminal loop is essential for calcium-mediated Tie2 inactivation. Next, by using lentiviruses encoding the full length, wild-type Tie2 or the Y1113F mutant fused to GFP to its C-terminus, we generated CHO cells stably expressing either Tie2-GFP or Tie2(Y1113F)-GFP (Figures IVA and IVB in the online-only Data Supplement) and investigated whether the Y1113F mutation affects Ang1dependent Tie2 signaling. Ang1 increased phosphorylation of Akt and extracellular signal-regulated kinase (ERK) both in cells expressing the wild-type and mutant Tie2 ( Figure IVC in the online-only Data Supplement). However, the basal levels of Akt and ERK phosphorylation were higher in cells expressing Tie2(Y1113F)-GFP than the wild-type Tie2-GFP-expressing cells ( Figure IVC , lane 5 in the online-only Data Supplement), suggesting that the basal activity of Tie2 may be suppressed by a calcium-and calmodulin-dependent mechanism. This is consistent with our result that depleting extracellular calcium ion and thereby decreasing intracellular calcium concentration increases the basal level of phosphorylation of Tie2ΔECD ( Figure 1D,  lane 3 versus lanes 5 and 7) . Calcium binding to calmodulin causes a conformational change, which often regulates its ability to bind to its targets. 24 Therefore, we next tested whether Tie2-calmodulin interaction Figure 3 . Role of Tyr1113 residue in calcium-induced Tie2 dephosphorylation. A, Either wild-type or Y1113F mutant FLAG-Tie2ΔECD construct together with HA-calmodulin were transfected into human embryonic kidney 293T cells (HEK293T) cells and treated with calcium ionophore as indicated. Phosphorylation of Tie2 in each condition was tested as in Figure 1C . B, The average degree of phosphorylation in calcium ionophore-treated cells compared with untreated controls is shown as a bar graph for each Tie2 construct. Error bars represent standard errors of 3 independent experiments. C, HEK293T cells transfected with FLAG-Tie2ΔECD or a control construct, integrin αIIb transmembrane domain-tail construct (αIIb-TAP) fused with N-terminal FLAG tag, and C-terminal tandem affinity purification tag containing the calmodulin-binding region. Cells were lysed, and the lysates were incubated with calmodulin beads in the presence of 2 mmol/L CaCl 2 or 10 mmol/L EDTA in the lysis buffer, and bead-bound proteins were analyzed by Western blot using anti-FLAG antibody (left). Aliquots of lysates used for the calmodulin binding experiment were analyzed to shown input levels (right). D, Lysates of HUVECs (upper) and HEK293T cells (lower panel) were incubated with calmodulin beads (or control beads) in the presence of 2 mmol/L CaCl 2 or 10 mmol/L EDTA, and the bound proteins were analyzed with anti-PTPRZ antibody. ECD indicates extracellular domain.
is regulated by calcium. Lysate of HEK239T cells transfected with Tie2ΔECD was incubated with calmodulin beads in the presence of calcium as before or in the presence of calcium chelator EDTA. In the experiment, removing calcium by EDTA did not disrupt this interaction ( Figure 3C, lanes 2 and 5) . In sharp contrast, addition of EDTA completely abolished calmodulin binding to a nonrelevant control protein (integrin αIIb transmembrane domain-cytoplasmic tail) containing a known calcium-dependent calmodulin-binding region 29 (Figure 3C,  lanes 3 and 6) . These results suggest that the Tie2-calmodulin interaction is maintained independently of intracellular calcium concentrations and that calmodulin bound to Tie2 may recruit a negative regulator in a calcium-dependent manner. As VE-PTP (or protein tyrosine phosphatase receptor type beta), a member of receptor-type protein tyrosine phosphatase family, is well-known as a negative regulator of Tie2 dephosphorylation, 30 it might be a candidate responsible for the calcium-and calmodulin-dependent Tie2 dephosphorylation. However, we observed calcium-dependent Tie2 dephosphorylation not only in endothelial cells (HUVECs, Figure 1B ) but also in epithelial cells (HEK293T, Figure 1C ), and the expression of VE-PTP seems to be restricted to endothelial cells. 18 Thus, we reasoned that other phosphatases capable of binding to calmodulin can also mediate calcium-induced Tie2 dephosphorylation. One possible candidate of such phosphatase we found is PTPRZ, another member of receptor-type protein tyrosine phosphatase family. The phosphatase is expressed in both endothelial and epithelial cells and interacts with calmodulin beads in a calcium-dependent manner ( Figure 3D ). However, we do not rule out the possible involvement of other tyrosine phosphatases in calcium-and calmodulin-dependent Tie2 dephosphorylation. Taken together, these results suggest that calcium-loaded calmodulin may recruit phosphatases, such as PTPRZ, which mediate calcium-and calmodulin-dependent Tie2 dephosphorylation and also suggest that VE-PTP may not be the only phosphatase that can mediate Tie2 dephosphorylation.
Expressing Tie2(Y1113F) or Inhibiting Calmodulin Function Causes Uncontrolled Angiogenesis In Vivo
Tie2 exhibits evolutionarily conserved amino acid sequences in vertebrates ( Figure 4A) . Particularly, the cytoplasmic domains of human and Xenopus Tie2 are highly conserved (94% amino acid identity and 96% similarity), and the key amino acids responsible for conformation of the C-terminal loop are identical in most vertebrates ( Figure 4A) . To understand the importance of the calmodulin-Tie2 interaction in vivo, we used the vertebrate animal model, Xenopus, in which a stereotyped pattern of vascular development can be efficiently visualized using fluorescent dyes 31 (Figure 4B ). The venous systems of zebrafish and Xenopus are particularly useful for studying developmental angiogenesis. 31, 32 In Xenopus, the posterior cardinal vein (PCV) extends longitudinally at the ventral trunk region from the heart to the cloaca, and intersomitic veins (ISVs) sprout off the PCV in a rostrocaudal sequence and grow dorsally 31 (Figure 4C) . At stage 42, the rostral-most two thirds of the ISVs can be clearly seen ( Figure 4C , asterisks, and Figure 4D ).
First, we knocked down the expression of Tie2 by introducing an antisense morpholino oligonucleotide (MO), which specifically binds to the 5′ untranslated region of the Tie2 mRNA and inhibits its translation by steric hindrance. 33 Knockdown of Tie2 did not perturb formation of either the heart or PCV, corroborating previous reports that vasculogenesis occurs normally in Tie2-null mice 5 and Tie2-depleted zebrafish 32 (Figure 4D ). However, development of ISVs from the PCV was significantly impaired, indicating that Tie2 function is required for sprouting and growth of the vasculature (Figure 4D) . At stage 42, when the normal embryo presented fully defined rostral ISVs (Figure 4D, top right panel) , Tie2depleted embryos showed much shorter ISVs (Figure 4D , bottom right panel). These results confirm previous findings that Tie2 signaling is required for developmental angiogenesis in vertebrates. 5, 32 To confirm that this defect is specific to the loss of Tie2 function, we investigated whether human Tie2 (hTie2) expression in these embryos can rescue the Tie2 knockdown phenotype (Figure 5A-5D ). First, we tested whether hTie2 is functional in Xenopus by asking whether Xenopus Ang1 can activate hTie2. We treated CHO cells stably expressing hTie2 with the culture medium harvested from cells transfected with Xenopus Ang1 or control plasmid. We found that Xenopus Ang1 was as efficient as recombinant human Ang1 in activating hTie2, as evidenced by increased Tie2 phosphorylation ( Figure VA in the online-only Data Supplement). This result indicates that Xenopus Ang1 can bind to and activate hTie2 and that expressing hTie2 is a valid strategy to rescue the loss of endogenous Tie2 in Xenopus. In accordance with the evolutionarily conserved role of Tie2 in angiogenesis, hTie2 almost completely restored the growth of ISV ( Figure 5C ). This indicates that the angiogenic defect in Tie2 MO-injected embryo was specifically because of the loss of Tie2 function. Next, we expressed the calmodulin binding-defective hTie2 mutant, hTie2(Y1113F), in Tie2-depleted embryos. This led to further increase in the lengths of the ISVs and strikingly complex branching patterns ( Figure 5D ). The different degree of rescue by hTie2 and hTie2(Y1113F) was not because of different levels of expression because the same amount of RNAs was injected and the similar amounts of wild-type and mutant Tie2 proteins were expressed in these embryos ( Figure VB in the online-only Data Supplement). This result indicates that the activity of hTie2(Y1113F) caused ISV hyperbranching ( Figure 5D ).
For quantitative analyses of the ISV phenotypes, we imaged individual embryos under a confocal microscope and traced the ISVs using the ImageJ plugin Simple Neurite Tracer, the software that allows semiautomatic tracing of tube-like structures through 3-dimensional image stacks. 34 We traced the 4 rostral-most ISVs in all embryos ( Figure  VIA -VID in the online-only Data Supplement) and quantified the phenotypes in several ways ( Figure 5G ). First, we measured the lengths of the ISVs. Tie2 MO-injected embryos had significantly shorter ISVs compared with the control MOinjected ones ( Figure 5H) . The defective phenotype observed in Tie2 MO-injected embryos was completely rescued on expressing either the wild-type hTie2 or hTie2(Y1113F), although the latter had a stronger effect ( Figure 5H ). Second, we counted the ISV branches ( Figure 5I ). Because the normal embryos have only a few ISV branches, injection of Tie2 MO did not result in a statistically significant reduction in the branch numbers, although Tie2 MO-injected embryos had no branches at all ( Figure 5I ). Expressing the wild-type hTie2 in Tie2 MO-injected embryos increased the number of ISV branches, comparable to that in the control ( Figure 5I ). For the same reason, however, the difference was not statistically significant. hTie2(Y1113F) expression, on the contrary, increased the number of ISV branches by over 8 times, and the difference was significant compared with all other groups ( Figure 5I ). Third, we found that both the wild-type hTie2 and hTie2(Y1113F) completely rescued the Tie2 MO-induced decrease in the total lengths of the ISV-associated vasculature ( Figure 5J ). Interestingly, hTie2(Y1113F) increased the total length of vasculature even when compared with the control MO-injected embryos ( Figure 5J ), making the ISV-associated vessels cover more areas of the body ( Figure 5D ). Finally, we found that hTie2(Y1113F)-expressing embryos had unusually complex branching patterns with increased number of highorder branches ( Figure 5K ), whereas Tie2 MO-injected, and even control MO-injected embryos, rarely had such branches ( Figure 5K ). To quantify the complexity of this vasculature, we used the branching complexity index, which was originally developed to analyze neuronal axonal arborization 35 ( Figure 5L ). The hTie2(Y1113F) expression led to a significant increase in vein complexity, indicating that Tie2(Y1113F) caused excessive branching. Having established that the calmodulin binding-defective mutant hTie2 causes excessive branching of the vasculature, we took an independent approach to address the involvement of calmodulin in this process. We treated W-7 to normally developing embryos at the onset of ISV formation and assessed the vessel growth ( Figure 5E and 5F) . We first optimized the W-7 regimen and found that treating embryos with 50 μmol/L W-7 from stage 33 to stage 42 (when ISV growth occurs) did not cause toxicity ( Figure VIE our model that calmodulin-mediated inhibition of Tie2 activity regulates vessel growth and branching. Together with our biochemical data, these in vivo data suggest that calmodulin might mediate calcium-mediated negative regulation of Tie2 activity and angiogenesis in vivo.
Discussion
In this study, we demonstrated that calcium signaling negatively regulates Tie2 phosphorylation, and this requires Tie2-calmodulin interaction. We also found that the Tyr1113 residue in the C-terminal loop of Tie2 is essential for calmodulin binding and calcium-mediated negative regulation. Finally, we showed that expressing calmodulin binding-defective Tie2 or inhibiting calmodulin function in vivo causes overgrowth and excessive branching of vessels, suggesting a novel mechanism by which calmodulin mediates calcium-mediated negative regulation of Tie2 activity and angiogenesis.
A potential negative role of Tyr1113 in Tie2 phosphorylation has been proposed previously. The first line of evidence came from an expression library screening study using the autophosphorylated kinase domain of Tie2. In the study, an SH2 domain-containing tyrosine phosphatase, SH-PTP2, was identified as a Tie2-binding protein, and this binding was suggested to depend on the phosphorylation of Tyr1113. 19 This raised the possibility that this Tyr residue might be responsible for Tie2 dephosphorylation by recruiting SH-PTP2 in a phosphorylation-dependent manner. Later studies, however, revealed that Tyr1113 is not essential for the interaction with SH-PTP2 because SH-PTP2 can bind Tie2 through phosphotyrosine residues other than Tyr1113 as well. 26 Moreover, Tie2 can phosphorylate SH-PTP2 even in presence of the Y1113F mutation, suggesting that SH-PTP2 is a downstream effector of Tie2, rather than its negative regulator. 36 Another line of evidence for the negative role of the Tyr1113 comes from a structural study. 27 The study showed that the Tie2 C-terminal loop region containing Tyr1113 partially occupies the ATP-binding site in the kinase domain, inhibiting the kinase activity of Tie2, and that Tyr1113 is required for the C-terminal loop to maintain this conformation. 27 Concordantly, deletion of the C-terminal loop enhanced Tie2 activity and its downstream signaling. 28 In addition, the Y1113F mutation, predicted to displace the inhibitory C-terminal loop region from the ATP-binding site, also enhanced the kinase activity of Tie2. 36 This model predicts that phosphorylation of Tyr1113 would, similar to Y1113F mutation, displace the C-terminal loop from the ATP-binding site and relieve its negative regulation. However, whether Tyr1113 is phosphorylated in vivo remains unclear because mass spectroscopy analysis failed to detect phosphorylated Tyr1113 even in a highly activated, autophosphorylated Tie2. 37 Similarly, phosphorylation of the Y1113 residue was not detected on Ang1-induced Tie2 phosphorylation. 36 Together, these studies implicate Tyr1113dependent conformation of the C-terminal loop in negative regulation of Tie2 activity. However, whether this is regulated by phosphorylation of Tyr1113 remains to be elucidated.
Here, we proposed a novel negative regulatory mechanism for Tie2 through the Tyr1113 residue. We show that Tyr1113 is essential for the Tie2-calmodulin interaction and calcium-induced Tie2 dephosphorylation. We also propose that conformation of the C-terminal loop, which requires Tyr1113, facilitates the binding of calmodulin in a calciumindependent manner and that the Tie2-bound calmodulin may recruit a phosphatase in response to increased calcium levels. Among the known Tie2-binding partners, the p85 subunit of phosphatidylinositol 3-kinase and growth factor receptor-bound protein 2 (Grb2)/Grb7 have been shown to bind to Tyr1102. 19, 26, 38 Further, downstream-of-kinaserelated, or Dok-R, is known to bind to activated Tie2 through Tyr1108, involved in the migration of endothelial cells. 39, 40 The only signaling molecule known to bind to Tyr1113 is SH-PTP2, 19 which can still bind Tie2 through other tyrosine residues as discussed earlier. Thus, we assume that the Y1113F mutant specifically disrupts the Tie2-calmodulin interaction while maintaining that of other known effectors. Consistently, we observed that Tie2 downstream signaling molecules, Akt and ERK, were activated by Ang1 treatment in the Y1113F-mutant Tie2-expressing cells ( Figure IVC Moving forth, we extended our biochemical studies to understand the significance of the results in formation of the vascular network during development. We found that Tie2 depletion causes a specific defect in the formation of ISVs, which sprout off from the PCV that spans the entire body. Our result is consistent with an earlier Tie2 knockout mouse study, which showed that Tie2 plays a more important role in angiogenesis than in vasculogenesis during development. 5 A more recent study using zebrafish showed that depleting Tie2 expression inhibits migration and proliferation of endothelial cells that give rise to ISVs, 32 supporting our interpretation that Tie2 signaling is required for developmental angiogenesis (however, see also Gjini et al, 41 which reports no apparent vessel abnormality in a Tie2 deletion mutant line). It was, however, unknown how endothelial cells terminate their growth to form ISVs of appropriate size and number of branches. We showed that expressing calmodulin binding-defective (Y1113F), but not wild-type Tie2, causes overgrowth and hyperbranching of the ISVs (Figure 6A and 6B ), suggesting that switching off Tie2 activity during embryonic angiogenesis requires calmodulin binding, and possibly, calcium signaling. Intriguingly, neutralizing antibodies against VE-PTP, a negative regulator of Tie2 activity, also induce uncontrolled vessel growth in allantois explants and juvenile mice, 30 consistent with our observation that a balanced Tie2 activity is key to normal vessel development.
The growth of a new vessel during angiogenesis is often compared with that of a neuronal axon because the 2 processes share cellular mechanisms and molecular effectors. 42 Specialized endothelial cells at the tip of a growing vessel, the tip cells, lead and guide the growth of the following vascular trail using highly dynamic filopodia. Therefore, they play a role almost identical to that of the axonal growth cone in axonal growth and guidance. 43 Moreover, extrinsic cues that guide axonal pathfinding by either attracting or repelling the growth cone (collectively known as axon guidance molecules) are also recognized by the tip cells because they express the receptors for axon guidance molecules. 44 Specifically, the stereotypical growth and restricted branching of the ISVs examined in our study are comparable to the growth pattern of motor and sensory neuronal axons through the somites. 45 Motor and sensory axons grow laterally near the surface of the anterior half of each somite owing to repulsive cues expressed in their posterior halves, notochord, and dermamyotomes-a mechanism known as surround repulsion. 46 Such cues include netrins and semaphorins. 46 Intriguingly, angiogenic stalk and tip endothelial cells also express receptors for these molecules, and their activation generally leads to the retraction of tip cell filopodia and vessel sprouting. 44 Particularly relevant is the study on the semaphorin receptor PlexinD1, in which its loss-offunction mutation in zebrafish resulted in exuberant branching of the ISVs. 47 This is similar to the phenotype that we observed in Xenopus expressing the calmodulin binding-defective Tie2 (Figure 5 ). In contrast, overexpression of the semaphorin ligand Sema3A inhibits the growth of ISVs, 47 a phenotype we observed in Tie2-depleted Xenopus embryos ( Figure 4) and Sema3A overexpressing Xenopus embryos (unpublished observation). More intriguingly, recent evidence suggests that Sema3A increases calcium influx through R-type calcium channels in cultured mouse sensory neurons. 48 We speculate that repulsive axon guidance molecules might coordinately regulate wiring of the nervous and vascular networks through shared effectors and mechanisms ( Figure 6C ), and this is an interesting direction of future studies.
In conclusion, our study highlights a novel connection between calcium and Tie2 signaling and a calcium/calmodulin-dependent Tie2 inactivation. We also show evidence that this mechanism of action may regulate embryonic vascularization in vivo. Given that negative regulation of Tie2 signaling is associated with pathological angiogenesis, we propose that relieving its negative regulation by inhibiting Tie2calmodulin interaction is a promising therapeutic approach for angiogenesis-related diseases. 
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